COMMUNIQUÉS West-GlobeNewswire

-
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
17/01/2024 -
Immatics Announces Proposed Public Offering
17/01/2024 -
Nextech Med Spa Software Launches Industry's Most Sophisticated Client Photo Functionalities
17/01/2024 -
Starton Therapeutics Announces STARTICLES Filing
17/01/2024 -
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
17/01/2024 -
EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
17/01/2024 -
Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE
17/01/2024 -
VIRBAC: Annual revenue growth of +4.9% thanks to record fourth-quarter activity at +11.5%
17/01/2024 -
VIRBAC: Croissance du chiffre d’affaires annuel à +4,9% grâce à un niveau record d’activité au quatrième trimestre à +11,5%
17/01/2024 -
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024
17/01/2024 -
Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédure de liquidation judiciaire au 31 janvier 2024
17/01/2024 -
Zealand Pharma major shareholder announcement: J O Hambro Capital Management
17/01/2024 -
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
17/01/2024 -
The Emily Program Announces Residential Treatment Expansion to Adults in Columbus, Ohio
17/01/2024 -
Trxade health, Inc files its 3Q 10Q
17/01/2024 -
Sienna Announces Fourth Quarter 2023 Results Release Date and Conference Call
17/01/2024 -
NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market
17/01/2024 -
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
17/01/2024 -
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
17/01/2024
Pages